Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Salona Global Medical Device ( (TSE:EVMT) ) just unveiled an update.
Evome Medical Technologies has announced a significant debt restructuring, reducing its debt from $6.7 million to $4.25 million, contingent upon monthly payments until 2030. As part of the restructuring, Evome’s subsidiary, Biodex Medical Systems, will extend a contract manufacturing agreement with Mirion Technologies, ensuring the production of Mirion’s products through March 2026, benefiting both parties and possibly stabilizing Evome’s financial standing.
More about Salona Global Medical Device
Evome Medical Technologies Inc. operates in the medical technology industry, focusing on the development and manufacturing of medical devices. The company is involved in various partnerships and agreements to enhance its product offerings and market reach.
YTD Price Performance: -25.00%
Average Trading Volume: 104,453
Technical Sentiment Consensus Rating: Buy
Current Market Cap: C$7.89M
Learn more about EVMT stock on TipRanks’ Stock Analysis page.